Gallbladder cancer: past, present and an uncertain future

Area of Science:

• Gastroenterology and Hepatobiliary Surgery
• Oncology

Background:

• Gallbladder cancer (GBC) is the most common biliary tract malignancy but has a low incidence and vague symptoms.
• Late diagnosis at presentation contributes to poor prognosis and decreased survival rates for GBC.
• GBC is often discovered incidentally after cholecystectomy, highlighting a need for better diagnostic and treatment strategies.

Purpose of the Study:

• To review the current understanding of gallbladder cancer (GBC) pathogenesis, diagnosis, staging, and natural history.
• To focus on surgical treatment and current adjuvant therapies for unresectable and advanced GBC.
• To identify prognostic factors and areas for future research to improve GBC treatment outcomes and survival.

Main Methods:

• Comprehensive literature review of current research on gallbladder cancer (GBC).
• Analysis of pathogenesis, risk factors, clinical presentation, and diagnostic modalities for GBC.
• Evaluation of surgical treatments, adjuvant therapies, and prognostic indicators for GBC.

Main Results:

• GBC remains poorly understood compared to other cancers, with late diagnosis being a significant issue.
• Understanding the clinical and molecular nuances of GBC is essential for developing early intervention and screening strategies.
• Current understanding of GBC pathogenesis, diagnosis, and treatment provides a basis for future research.

Conclusions:

• Improved understanding of GBC pathogenesis and risk factors is critical for early diagnosis.
• Further research into GBC's clinical and molecular aspects is needed for effective treatment strategies.
• Enhanced knowledge of GBC will hopefully lead to improved treatment outcomes and overall survival for this challenging malignancy.